CATALOGO DEI PRODOTTI DELLA RICERCA

BERTOLDO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.085
NA - Nord America 6.319
AS - Asia 4.843
SA - Sud America 805
AF - Africa 90
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.159
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.233
RU - Federazione Russa 2.365
SG - Singapore 2.033
GB - Regno Unito 1.972
CN - Cina 1.561
BR - Brasile 661
IT - Italia 555
SE - Svezia 440
HK - Hong Kong 424
FR - Francia 403
DE - Germania 397
FI - Finlandia 338
IE - Irlanda 321
VN - Vietnam 295
KR - Corea 146
UA - Ucraina 108
TR - Turchia 79
AR - Argentina 53
ID - Indonesia 52
IN - India 52
CA - Canada 39
JP - Giappone 35
NL - Olanda 35
AE - Emirati Arabi Uniti 34
MX - Messico 31
BD - Bangladesh 26
ZA - Sudafrica 25
EC - Ecuador 21
ES - Italia 19
CL - Cile 17
PL - Polonia 16
RO - Romania 16
AT - Austria 15
BE - Belgio 15
IQ - Iraq 15
CO - Colombia 13
EE - Estonia 13
EG - Egitto 13
PK - Pakistan 13
VE - Venezuela 13
IR - Iran 12
CZ - Repubblica Ceca 11
PY - Paraguay 11
AU - Australia 10
LT - Lituania 10
BJ - Benin 9
MA - Marocco 8
MY - Malesia 7
OM - Oman 7
PE - Perù 7
SK - Slovacchia (Repubblica Slovacca) 7
DZ - Algeria 6
IL - Israele 6
JO - Giordania 6
KE - Kenya 6
UY - Uruguay 6
CR - Costa Rica 5
TG - Togo 5
UZ - Uzbekistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BG - Bulgaria 4
HU - Ungheria 4
BO - Bolivia 3
DK - Danimarca 3
HR - Croazia 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
RS - Serbia 3
TN - Tunisia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
IS - Islanda 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NG - Nigeria 2
PH - Filippine 2
PR - Porto Rico 2
SA - Arabia Saudita 2
SN - Senegal 2
AL - Albania 1
AO - Angola 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EU - Europa 1
GH - Ghana 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
MK - Macedonia 1
Totale 19.141
Salva come PNG Salva come JPEG
Città #
Southend 1.775
Singapore 996
Jacksonville 979
Chandler 816
Moscow 698
Dallas 595
Ashburn 428
Hong Kong 413
Ann Arbor 388
Woodbridge 377
Houston 319
Dublin 318
Beijing 208
Princeton 149
Lawrence 148
Wilmington 137
New York 125
Nanjing 124
Los Angeles 115
Jinan 109
Verona 109
Shenyang 97
Ho Chi Minh City 96
The Dalles 85
Buffalo 80
Milan 76
Hebei 74
Changsha 69
Sindelfingen 69
Boardman 67
Helsinki 66
Tianjin 63
São Paulo 59
Hanoi 54
Munich 54
Nanchang 53
Redondo Beach 51
Ningbo 48
Zhengzhou 41
Bologna 39
Taizhou 36
Haikou 35
Jakarta 33
Jiaxing 33
Hangzhou 32
Tokyo 32
London 31
Chicago 29
San Francisco 28
Dearborn 27
Santa Clara 27
Columbus 26
Lancaster 24
Guangzhou 23
Rome 23
Rio de Janeiro 21
Falls Church 19
Turku 19
Montreal 18
Norwalk 18
Fuzhou 17
Orem 17
Dong Ket 16
Seoul 16
Taiyuan 16
Brussels 15
Council Bluffs 15
Detroit 15
Paris 15
Phoenix 15
Seattle 15
Stockholm 15
Brooklyn 14
Curitiba 14
Johannesburg 14
Belo Horizonte 13
Boston 13
Lappeenranta 13
Denver 12
Mexico City 12
Redmond 12
San Jose 12
Warsaw 12
Da Nang 11
Falkenstein 11
Haiphong 11
Lanzhou 11
Nuremberg 11
Washington 11
Atlanta 10
Brasília 10
Fairfield 10
Florianópolis 10
Frankfurt am Main 10
Porto Alegre 10
San Giovanni Lupatoto 10
Cotonou 9
Dhaka 9
Quito 9
Toronto 9
Totale 11.601
Salva come PNG Salva come JPEG
Nome #
Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro. 245
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation 229
Adipocytes IGFBP-2 expression in prepubertal obese children. 226
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 224
Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells 222
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 212
The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells 209
Age-related bone loss in postmenopausal women 207
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 203
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 203
STEAP mRNA detection in serum of patients with solid tumours. 198
Bone metabolism in patients with anorexia nervosa and amenorrhoea 198
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 193
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 191
Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. 190
BISPHOSPHONATES DECREASE HTERT IN PC3 AND DU-145 PROSTATE CANCER CELLS 187
Bone development during GH and GnRH analog treatment 175
A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: Prednisone versus Deflazacort. 174
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 174
Histomorphometric analysis of glucocorticoid-induced osteoporosis 172
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 172
Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020 170
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 169
Altered bone metabolism in children infected with human immunodeficiency virus. 168
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 167
Blood ionized calcium is associated with clustered polymorphism in the carboxyl-terminal tail of the calcium-sensing receptor. 165
Incidenza di ipovitaminosi D nel Nord Italia 165
The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene? 160
Bisphosphonates and osteonecrosis of the mandible/maxilla in osteoporosis: no reason to panic 160
Guidelines for the diagnosis, prevention and management of osteoporosis 159
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 157
ARTROPATIE DISMETABOLICHE 155
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 155
Bone microarchitecture evaluated by histomorphometry 152
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 151
Bisfosfonati e metastasi ossee:up-to-date 2005 150
Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment 148
Acute effects of deflazacort and prednisone on rates of mineralization and bone formation 145
Osteopenia induced by immunosuppressive drugs in rats. Histomorphometric analisys of risedronate effects. 144
Bone Microarchitecture in Mild Primary Hyperparathyroidism 143
Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease. 143
GAPDH: CONSTITUTIVE HOUSEKEEPING GENE OR TARGET FOR THERAPEUTIC INTERVENTION? 138
Artropatie dismetaboliche 138
The renal handling of calcium: influence of parathyroid hormone secretion 136
Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle. 135
Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. 134
emerging drugs for the management of cancer treatment induced bone loss 134
[Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project] 133
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 130
YEARS BOOK 2006 . BISFOSFONATI E ONCOLOGIA 130
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 129
PEAK BONE MASS AND BODY COMPOSITION IN PRECOCIOUS PUBERTY AFTER GNRH AGONIST THERAPY WITH AND WITHOUT CALCIUM SUPPLEMENTATION 129
Biology and Pathophysiology of Bone Metastasis in Prostate Cancer 129
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 129
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 129
Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO) 128
Drug-induced osteonecrosis of the jaw: the state of the art 127
Impact of the Visceral Adipose Tissue on Bone Quality in Patients with Untreated mild-to-severe Obstructive Sleep Apnoea 126
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 126
Incidenza di ipovitaminosi D nel Nord Italia 125
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 124
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 123
CALCIUM SUPPLEMENTATION, OESTROGENS AND BONE DENSITY IN GNRHA TREATED PRECOCIOUS PUBERTY 122
The use of dichloromethylene bisphosphonate and aminobutanebisphosphonate in hypercalcemia of malignancy. 122
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 122
EFFETTO DI UN AGONISTA DEL GNRH AD AZIONE PROLUNGATA (LEUPROLIDE ACETATO) SULLO STATO DI MINERALIZZAZIONE OSSEA IN BAMBINE CON PUBERTA' PRECOCE 121
Regulation of calcium-parathyroid hormone feedback in primary htperparathyroidism effcts of bisphosphonate treatment 121
Bone mineral density and metabolism in HIV-infected children 120
the use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemnia of malignanacy 120
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 120
The prevention of corticosteroid-induced osteoporosis with nandrolone decantate Bone and Mineral 15, 72-81 (1991) 119
Serum 25-hydroxy vitamin D and exercise capacity in COPD. 119
Effects of a 4400 km ultra-cycling non-competitive race and related training on body composition and circulating progenitors differentiation 118
Bone Mineral Density in Mountain, Road Cyclists and Untrained Controls: Exercise, Diet and Hormones 117
Valutazione della microarchitettura ossea nell'iperparatiroidismo primitivo 117
Transdermal estradiol in the treatment of postmenopausal bone loss. 117
Final peak bone mass in precocious puberty after GhRH agonist therapy with and without calcium supplementation 116
Transdermal Estradiol in the treatment of postmenopausale bone loss. 116
Calcium Supplementation Increases Bone Mass in GH-Deficient Prepubertal Children during GH Replacement 116
intramuscolar neridronate in postmenopausal women with low bone mineral density 116
Physiopatology of bone metastases 115
Sodium requirements regulates renal tubular reabsorption of calcium 113
The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study 113
HIV-infected children and bone mineral density 112
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiopathic hypercalcemia and with primary hyperparathyroidism 112
Effects of two oral doses of alendronate in the treatment of Paget’s disease of bone. 112
Osteomalacia: The missing link in the pathogenesis of Bisphosphonate-related osteonecrosis of the jaws? 110
The Effect of Bisphosphonates on Gene Expression: The GAPDH as a Housekeeping or a New Target Gene? 109
Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy 107
Treatment thresholds for osteoporosis and reimbursability criteria: perspectives associated with fracture risk-assessment tools. 107
Ruolo dei bisfosfonati nella terapia dell'osteoporosi 106
Intramuscular neridronate in postmenopausal women with low bone mineral density 105
Obesità e osteoporosi 105
Effetto dell'alendronato sulle caratteristiche strutturali e biomeccaniche dell'osso corticale 104
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiophatic hypercalciuria and primary hyperparathyroidism 103
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 103
nUOVE PROSPETTIVE NELL'UTILIZZO DEI BISFOSFONATI IN ONCOLOGIA:OLTRE LA METASTASI OSSEA 102
Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteopororis fractures 101
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary 101
A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis 101
Totale 14.342
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.053
article - articoli 57.455
book - libri 1.098
conference - conferenze 3.274
curatela - curatele 0
other - altro 201
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.025
Totale 130.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021546 0 0 0 0 0 125 25 108 112 6 132 38
2021/20221.251 96 389 6 101 48 48 14 61 39 27 122 300
2022/20232.308 218 196 274 364 227 524 12 134 240 24 73 22
2023/20241.191 53 89 131 135 170 169 59 74 7 50 159 95
2024/20253.153 188 199 113 478 170 75 182 184 461 228 213 662
2025/20265.749 640 469 763 1.356 2.035 486 0 0 0 0 0 0
Totale 19.322